New Italian Pricing Decree To Drive R&D Transparency
Companies Are Concerned That Revealing R&D Funding will Reduce Prices
Following on from moves to push price transparency on to the global agenda, Italy is poised to pass a decree that would oblige companies to disclose public R&D funding.
You may also be interested in...
Draft guidelines due out for consultation this week in Italy are expected to shed more light on what companies will have to reveal during pricing and reimbursement negotiations.
Last week the World Trade Organization’s TRIPS Council discussed transparency in medicine pricing, including R&D costs.
A draft decree in Italy aims to put added therapeutic value at the centre of reimbursement decisions.